Variant report

Variant	nsv518227
Chromosome Location	chr2:9893454-9909114
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:43)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:43 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:9842465..9843983-chr2:9901077..9903005,2	K562	blood:
2	chr2:9901947..9904351-chr2:9980319..9983166,2	K562	blood:
3	chr2:9851071..9852686-chr2:9893395..9896154,2	K562	blood:
4	chr2:9899081..9899639-chr3:43902591..43903091,2	MCF-7	breast:
5	chr2:9886336..9889527-chr2:9892124..9895525,3	MCF-7	breast:
6	chr2:9695083..9696978-chr2:9901909..9904289,2	K562	blood:
7	chr2:9887703..9890322-chr2:9895249..9898241,2	MCF-7	breast:
8	chr2:9748514..9750852-chr2:9899112..9901012,2	K562	blood:
9	chr2:9893059..9895633-chr2:9899321..9902671,3	K562	blood:
10	chr2:9907890..9909492-chr2:9937494..9939085,2	MCF-7	breast:
11	chr2:9901768..9906137-chr2:9907161..9912624,7	K562	blood:
12	chr2:9893434..9894306-chr6:31619956..31620466,2	Hela-S3	cervix:
13	chr2:9769465..9771983-chr2:9905092..9906674,2	MCF-7	breast:
14	chr2:9900453..9903358-chr2:9916510..9918074,2	K562	blood:
15	chr2:9888046..9890254-chr2:9893584..9895138,2	K562	blood:
16	chr2:9897831..9899412-chr2:9902196..9904626,2	MCF-7	breast:
17	chr2:9909026..9912481-chr2:10259443..10262566,4	K562	blood:
18	chr2:9892015..9894940-chr2:9904744..9907619,3	K562	blood:
19	chr2:9897830..9899713-chr2:9900837..9903744,2	K562	blood:
20	chr2:9892015..9894940-chr2:9904744..9907619,3	K562	blood:
21	chr2:9893059..9895633-chr2:9899321..9902671,3	K562	blood:
22	chr2:9893534..9896583-chr2:9907885..9911717,3	K562	blood:
23	chr2:9780247..9783706-chr2:9899815..9903353,3	K562	blood:
24	chr2:9769153..9773017-chr2:9899930..9902488,4	K562	blood:
25	chr2:9904685..9905408-chr2:9918226..9918742,2	K562	blood:
26	chr2:9895791..9898200-chr2:9907765..9909723,2	MCF-7	breast:
27	chr2:9892015..9895829-chr2:9904744..9907713,4	K562	blood:
28	chr2:9902911..9905269-chr2:9908747..9910675,2	K562	blood:
29	chr2:9897831..9899412-chr2:9902196..9904626,2	MCF-7	breast:
30	chr2:9897337..9900295-chr2:9937034..9939837,3	K562	blood:
31	chr2:9891910..9893733-chr2:9895279..9898420,3	MCF-7	breast:
32	chr2:9904753..9906453-chr2:9909403..9911953,2	MCF-7	breast:
33	chr2:9891910..9893733-chr2:9895279..9898420,3	MCF-7	breast:
34	chr2:9907009..9909399-chr2:10572837..10575430,2	K562	blood:
35	chr2:9895791..9898200-chr2:9907765..9909723,2	MCF-7	breast:
36	chr2:9768478..9773645-chr2:9894224..9897405,4	K562	blood:
37	chr2:9772230..9774093-chr2:9892101..9894340,2	MCF-7	breast:
38	chr2:9891163..9893022-chr2:9896031..9898454,2	K562	blood:
39	chr2:9694937..9699400-chr2:9908606..9911252,4	K562	blood:
40	chr2:9892798..9893661-chr3:149530498..149531325,2	Hela-S3	cervix:
41	chr2:9897830..9899713-chr2:9900837..9903744,2	K562	blood:
42	chr2:9892015..9895829-chr2:9904744..9907713,4	K562	blood:
43	chr2:9769789..9771364-chr2:9892124..9894482,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-YWHAQ-1	chr2:9897625-9899428	XLOC_001982

No data

Variant related genes	Relation type
ENSG00000204463	chromatin interactions
ENSG00000151694	chromatin interactions
ENSG00000243491	chromatin interactions
ENSG00000171848	chromatin interactions
ENSG00000134308	chromatin interactions
ENSG00000082996	chromatin interactions
ENSG00000240960	chromatin interactions
ENSG00000204444	chromatin interactions
ENSG00000271855	chromatin interactions
ENSG00000272524	chromatin interactions

Extended variants
information (count: 671 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:671 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13412895	chr2:9893454-9893455	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs574567213	chr2:9893480-9893481	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs569294816	chr2:9893497-9893498	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs73160411	chr2:9893528-9893529	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs142276967	chr2:9893586-9893587	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
6	rs5829236	chr2:9893587-9893588	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
7	rs3029254	chr2:9893612-9893613	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
8	rs371802316	chr2:9893613-9893614	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
9	rs558119393	chr2:9893616-9893617	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
10	rs571398961	chr2:9893636-9893637	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
11	rs189305432	chr2:9893654-9893655	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs552175122	chr2:9893693-9893694	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs67071207	chr2:9893702-9893703	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs573616256	chr2:9893716-9893717	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs149905543	chr2:9893743-9893744	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs67169917	chr2:9893755-9893756	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs199952609	chr2:9893769-9893770	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs1110317	chr2:9893770-9893771	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs34116300	chr2:9893776-9893777	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs201338064	chr2:9893777-9893778	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs578116453	chr2:9893807-9893808	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs545019992	chr2:9893808-9893809	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs540431125	chr2:9893813-9893814	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs560739234	chr2:9893849-9893850	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs6734361	chr2:9893883-9893884	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs112029141	chr2:9893889-9893890	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs562855928	chr2:9893902-9893903	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs374286227	chr2:9893906-9893907	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs376778810	chr2:9893913-9893914	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs534105853	chr2:9893928-9893929	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs868442	chr2:9893964-9893965	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs369544186	chr2:9893975-9893976	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs6752317	chr2:9894043-9894044	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs546342811	chr2:9894058-9894059	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs575625799	chr2:9894066-9894067	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs141051221	chr2:9894087-9894088	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs558532644	chr2:9894115-9894116	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs578148365	chr2:9894122-9894123	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs6705016	chr2:9894123-9894124	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs560446173	chr2:9894160-9894161	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs574319551	chr2:9894165-9894166	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs576627159	chr2:9894175-9894176	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs563019587	chr2:9894197-9894198	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs369211954	chr2:9894205-9894206	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs375580610	chr2:9894220-9894221	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs542165888	chr2:9894236-9894237	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs6705151	chr2:9894237-9894238	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs181629736	chr2:9894273-9894274	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs565286926	chr2:9894298-9894299	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs527565562	chr2:9894326-9894327	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Mental retardation	17847001	CNVD
Glioblastoma multiforme	21080181	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Cancer	20164920	CNVD
Neuroblastoma	21508638	CNVD
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Ependymoma	16718352	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Glioma	17123091	CNVD
Breast cancer	20409316	CNVD
Multiple myeloma	16616336	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Neuroblastoma	18923524	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:919 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:9889800-9896800	Enhancers	Skeletal Muscle Female	skeletal muscle
2	chr2:9890800-9894200	Enhancers	Skeletal Muscle Male	skeletal muscle
3	chr2:9890800-9895800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
4	chr2:9891000-9895800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
5	chr2:9891600-9896800	Weak transcription	Psoas Muscle	Psoas
6	chr2:9892000-9894200	Enhancers	Primary monocytes fromperipheralblood	blood
7	chr2:9892000-9897800	Bivalent Enhancer	Fetal Muscle Leg	muscle
8	chr2:9892400-9895600	Enhancers	Primary T helper cells fromperipheralblood	blood
9	chr2:9892400-9898600	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr2:9892600-9893600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr2:9892600-9893600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
12	chr2:9892600-9893800	Enhancers	H9 Cell Line	embryonic stem cell
13	chr2:9892600-9893800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
14	chr2:9892600-9893800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr2:9892600-9893800	Flanking Bivalent TSS/Enh	HepG2	liver
16	chr2:9892600-9893800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
17	chr2:9892600-9893800	Flanking Active TSS	Osteobl	bone
18	chr2:9892600-9894200	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr2:9892600-9894200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
20	chr2:9892600-9894400	Flanking Active TSS	A549	lung
21	chr2:9892600-9894600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr2:9892600-9894600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr2:9892600-9894600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
24	chr2:9892600-9894800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr2:9892600-9894800	Enhancers	Fetal Intestine Large	intestine
26	chr2:9892600-9894800	Enhancers	Fetal Intestine Small	intestine
27	chr2:9892600-9895000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
28	chr2:9892600-9895200	Flanking Active TSS	Hela-S3	cervix
29	chr2:9892600-9895600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr2:9892600-9897600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr2:9892800-9893800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr2:9892800-9893800	Flanking Active TSS	HSMMtube	muscle
33	chr2:9892800-9894000	Flanking Active TSS	Muscle Satellite Cultured Cells	--
34	chr2:9892800-9894000	Enhancers	Placenta Amnion	Placenta Amnion
35	chr2:9892800-9894400	Enhancers	HUES64 Cell Line	embryonic stem cell
36	chr2:9892800-9894800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
37	chr2:9892800-9894800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
38	chr2:9892800-9894800	Bivalent Enhancer	Placenta	Placenta
39	chr2:9892800-9894800	Enhancers	Pancreas	Pancrea
40	chr2:9892800-9894800	Flanking Active TSS	NHEK	skin
41	chr2:9892800-9895000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr2:9892800-9895000	Enhancers	HUES6 Cell Line	embryonic stem cell
43	chr2:9892800-9895000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
44	chr2:9892800-9895200	Enhancers	H1 Cell Line	embryonic stem cell
45	chr2:9892800-9895200	Enhancers	Spleen	Spleen
46	chr2:9892800-9895400	Enhancers	Cortex derived primary cultured neurospheres	brain
47	chr2:9892800-9895400	Enhancers	Thymus	Thymus
48	chr2:9892800-9895600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
49	chr2:9892800-9895800	Enhancers	Fetal Thymus	thymus
50	chr2:9892800-9897400	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links